Font Size:

Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2024

2023

% Change

2023

2022

2021

2020

2019

Acute Flaccid Myelitis

0 0 -- 0 2 1 0^ 0^

Anthrax

0 0 -- 0 0 0 0 0

Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus)

0 1 -100.0% 32 5 12 10 6

Babesiosis

2 1 100.0% 1 0 1 1 4

Botulism

0 0 -- 2 2 0 1 1

Brucellosis

0 0 -- 1 0 1 1 4

Campylobacteriosis

246 259 -5.0% 879 813 745 665 754

Chikungunya virus - travel related, acquired out of state

0 1 -100.0 1 0 0 0 0

Cholera

0 0 -- 0 0 0 0 0

Coccidioidomycosis

2 2 0.0% 12 12 13 5 9

Cryptosporidiosis

52 63 -17.5% 213 158 125 138 225

Cyclosporiasis

0 7 -100.0% 140 19 6 9 4

Dengue - travel related, acquired out of state

1 1 0.0% 5 5 1 0 3

E. coli, shiga toxin-producing (includes O157: H7)

33 43 -23.3% 169 161 143 100 138

Ehrlichiosis/Anaplasmosis

1 0 -- 5 11 24 12 39

Hansen's Disease (Leprosy)

0 0 -- 2 0 0 1 1

Hemolytic uremic syndrome (HUS)

0 0 -- 6 10 3 3 6

Influenza-associated pediatric mortality

1 1 0.0% 1 3 0 1 2

Legionellosis

17 15 13.3% 66 65 89 61 72

Listeriosis

1 4 -75.0% 16 12 12 14 7^

Lyme disease

7 8 -12.5% 36 32 51 15 66

Malaria - travel related, acquired out of state

1 5 -80.0% 11 8 8 2 9

Novel Influenza A virus infection

0 0 -- 0 0 0 0 0

Paratyphoid Fever

0 0 -- 0 2 2 1 1^

Plague

0 0 -- 0 0 0 0^ 0

Primary Amebic Meningoencephalitis (Naegleria fowleri)

0^

--

--

--

--

--

--

--

Q fever

0 1 -100.0% 2 3 2 0 2

Rabies, animal

7 12 -41.7% 38 45 44 51 50

Rabies, human

0 0 -- 0 0 0 0 0

Salmonellosis

152 167 -9.0% 879 996 861 891 1001

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0 0 -- 0 0 0 0 0

Shigellosis

35 29 20.7% 100 81 88 346 433

Smallpox

0 0 -- 0 0 0 0 0

Spotted Fever Rickettsiosis

6 21 -71.4% 81 118 122 90 476^

Trichinellosis (Trichinosis)

0 0 -- 0 0 1 0 0

Tularemia

0 0 -- 1 3 0 1 4

Typhoid fever

0 0 -- 2 0 3 1 0

Vibriosis (non-Cholera)

9 13 -30.8% 37 41 34 26 41^

Viral hemorrhagic fever

0 0 -- 0 0 0 0 0

VISA (Staphylococcus aureus, vancomycin-intermediate)

0 0 -- 1 1 1 0 1

VRSA (Staphylococcus aureus, vancomycin-resistant)

1 0 -- 0 0 1 1 2

Yellow Fever

0 0 -- 0 0 0 0 0^

Zika virus - travel related, acquired out of state

0 0 -- 0 0 0 0 0

Other Investigations

1 1 0.0% 5 0 1 0 3

Total

575 655 -12.2% 2744 2608 2395 2447 3360

NOTE: Counts include finalized investigations among Alabama residents as of May 6, 2024. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 18 (week ending May 4, 2024), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.





Page last updated: May 7, 2024